Navigation Links
New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
Date:6/24/2013

BOSTON, June 24, 2013 /PRNewswire/ --

During the Drug Information Association's (DIA) annual meeting today, Veeva Systems previewed its new Veeva Vault Investigator Portal. As a companion product to Vault eTMF, Vault Investigator Portal enables fast collection, sharing and tracking of all investigator content from a single platform. Veeva has specifically designed its new Investigator Portal to speed study start-up by simplifying the overall trial document management process and providing bi-directional, direct access to the eTMF.

     (Logo: http://photos.prnewswire.com/prnh/20120425/527164)

     (Photo: http://photos.prnewswire.com/prnh/20130624/622707 )

Clinical trials are one of the most complex areas of a life sciences company's operations, requiring global reach, coordination and tracking across multiple stakeholders. Investigators and site personnel spend hundreds of hours performing redundant tasks across multiple sponsors and systems. Most trial technologies hinder investigator efficiency and breed frustration. Veeva's cloud-based Vault Investigator Portal orchestrates collaboration with site personnel for more efficient operations.

"Without a doubt, the back and forth between investigators and the CRO or sponsor is causing huge delays in study start-up. Most of these documents are still exchanged as paper, which is slow and adds expense. Sponsors and CROs must find ways to improve the efficiency while protecting the increasingly important site relationship," said Michael Burton, director of clinical product strategy at Veeva.

Veeva's Vault Investigator Portal helps streamline trials and increase efficiency with features that lessen the workload for sponsors and investigators, including:  

  • Single source for sponsors, CROs and investigator sites to submit and access documents
  • Direct placement of site documents into the eTMF
  • Two-way channel for exchanging documents, including safety alerts and site training videos
  • Prioritized to-do lists and associated documents packaged and pushed to investigator sites

"With Vault Investigator Portal, sponsors and CROs will benefit from better document tracking and placement into the eTMF," concluded Burton. "The ease-of-use and efficiency for investigators will make working with the sponsor and CRO more attractive, which should keep investigators coming back for trial after trial."

Also announced at DIA 2013 today, Veeva adds critical publishing capabilities to Vault Submissions - the industry's first cloud-based application for managing submissions content. Visit the company's booth # 1557 for demonstrations of the new Vault Investigator Portal as well as Vault Submissions.

About Veeva Vault Development Suite

Vault Investigator Portal is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation.

About Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information, visit http://www.veeva.com.

Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

Media Contact
Lisa Barbadora
Veeva Systems, Inc.  
pr@veevasystems.com


'/>"/>
SOURCE Veeva Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IMS Health Advances Cloud-Based Social Media Analytics with Acquisition of Semantelli
2. The House Call Reinvented: Video Creates Personal Doctor-Patient Connection Via Cloud-Based Remote Patient Monitoring Service
3. Amdocs Launches Cloud-Based eHealth Solutions to Give Service Providers Fast Entry to Growing Market
4. Desitin Pharmaceuticals Selects Cloud-Based Veeva CRM to Support Expansion into the UK Market
5. Proton Pharma and Rottapharm Switch to Cloud-Based Veeva CRM for its Flexibility to Meet Unique Local Needs in Greece
6. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
7. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
8. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators
11. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different ... purpose as the host of the “Informed” series. The program focuses on many important ... series focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of ...
Breaking Medicine News(10 mins):